Centre for International Child Health, University of Melbourne, MCRI, The Royal Children's Hospital, Parkville, Victoria, Australia
Department of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
BMJ Glob Health. 2022 Aug;7(8). doi: 10.1136/bmjgh-2022-009278.
Improving hospital oxygen systems can improve quality of care and reduce mortality for children, but we lack data on cost-effectiveness or sustainability. This study evaluated medium-term sustainability and cost-effectiveness of the Nigeria Oxygen Implementation programme.
Prospective follow-up of a stepped-wedge trial involving 12 secondary-level hospitals. Cross-sectional facility assessment, clinical audit (January-March 2021), summary admission data (January 2018-December 2020), programme cost data.
pulse oximetry introduction followed by solar-powered oxygen system installation with clinical and technical training and support.
(i) proportion of children screened with pulse oximetry; (ii) proportion of hypoxaemic (SpO <90%) children who received oxygen. Comparison across three time periods: preintervention (2014-2015), intervention (2016-2017) and follow-up (2018-2020) using mixed-effects logistic regression. Calculated cost-effectiveness of the intervention on child pneumonia mortality using programme costs, recorded deaths and estimated counterfactual deaths using effectiveness estimates from our effectiveness study. Reported cost-effectiveness over the original 2-year intervention period (2016-2017) and extrapolated over 5 years (2016-2020).
Pulse oximetry coverage for neonates and children remained high during follow-up (83% and 81%) compared with full oxygen system period (94% and 92%) and preintervention (3.9% and 2.9%). Oxygen coverage for hypoxaemic neonates/children was similarly high (94%/88%) compared with full oxygen system period (90%/82%). Functional oxygen sources were present in 11/12 (92%) paediatric areas and all (8/8) neonatal areas; three-quarters (15/20) of wards had a functional oximeter. Of 32 concentrators deployed, 23/32 (72%) passed technical testing and usage was high (median 10 797 hours). Estimated 5-year cost-effectiveness US$86 per patient treated, $2694-4382 per life saved and $82-125 per disability-adjusted life year-averted. We identified practical issues for hospitals and Ministries of Health wishing to adapt and scale up pulse oximetry and oxygen.
Hospital-level improvements to oxygen and pulse oximetry systems in Nigerian hospitals have been sustained over the medium-term and are a highly cost-effective child pneumonia intervention.
改善医院氧气系统可以提高儿童的护理质量并降低死亡率,但我们缺乏关于成本效益或可持续性的数据。本研究评估了尼日利亚氧气实施计划的中期可持续性和成本效益。
对一项涉及 12 所二级医院的阶梯式试验进行前瞻性随访。进行设施横断面评估、临床审计(2021 年 1 月至 3 月)、总结入院数据(2018 年 1 月至 2020 年 12 月)和方案成本数据。
脉搏血氧仪引入,随后安装太阳能氧气系统,同时提供临床和技术培训及支持。
(i)接受脉搏血氧仪筛查的儿童比例;(ii)接受氧气治疗的低氧血症(SpO <90%)儿童比例。使用混合效应逻辑回归方法,在三个时间段(预干预期(2014-2015 年)、干预期(2016-2017 年)和随访期(2018-2020 年))进行比较。使用方案成本、记录的死亡人数和使用我们的有效性研究中的有效性估计值估算的估计反事实死亡人数,计算出儿童肺炎死亡率的干预成本效益。报告了原始 2 年干预期(2016-2017 年)的成本效益,并进行了 5 年(2016-2020 年)的外推。
与全氧气系统期(94%和 92%)和预干预期(3.9%和 2.9%)相比,新生儿和儿童的脉搏血氧仪覆盖率在随访期间仍保持较高水平(83%和 81%)。低氧血症新生儿/儿童的氧气覆盖率也较高(94%/88%)。12 个儿科区域中 11 个(92%)和所有 8 个新生儿区域(88%)都有功能齐全的氧气源;8 个病房中有 6 个(75%)配备了功能齐全的血氧计。32 个集中器中,有 23 个(72%)通过了技术测试,使用率很高(中位数为 10797 小时)。估计 5 年的成本效益为每位治疗患者 86 美元,每挽救 1 条生命的成本效益为 2694-4382 美元,每避免 1 个残疾调整生命年的成本效益为 82-125 美元。我们发现了医院和卫生部希望适应和扩大脉搏血氧仪和氧气使用范围所面临的实际问题。
尼日利亚医院在提高氧气和脉搏血氧仪系统方面取得了医院层面的中期进展,这是一种具有高度成本效益的儿童肺炎干预措施。